The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus.
Hong Yang
No relevant relationships to disclose
Jianhua Fu
No relevant relationships to disclose
Mengzhong Liu
No relevant relationships to disclose
Wentao Fang
No relevant relationships to disclose
Jiaming Wang
No relevant relationships to disclose
Yuping Chen
No relevant relationships to disclose
Zhijian Chen
No relevant relationships to disclose
Chengchu Zhu
No relevant relationships to disclose
Jiaqing Xiang
No relevant relationships to disclose
Huanjun Yang
No relevant relationships to disclose
Zhengtao Yu
No relevant relationships to disclose
Qingsong Pang
No relevant relationships to disclose
Weimin Mao
No relevant relationships to disclose
Xiao Zheng
No relevant relationships to disclose
Yongtao Han
No relevant relationships to disclose